Across TCGA pan-cancer cohorts, MIR137HG RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MIR137HG data layer compared with 1 for mutation status.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR137HG RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR137HG expression acts as an unfavorable survival marker, although some lineages such as ACC and CHOL show a favorable association.
KIRP, LIHC, and HNSC are the cancer types where MIR137HG RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.